KR920002151A - 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료 - Google Patents

15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료 Download PDF

Info

Publication number
KR920002151A
KR920002151A KR1019910011731A KR910011731A KR920002151A KR 920002151 A KR920002151 A KR 920002151A KR 1019910011731 A KR1019910011731 A KR 1019910011731A KR 910011731 A KR910011731 A KR 910011731A KR 920002151 A KR920002151 A KR 920002151A
Authority
KR
South Korea
Prior art keywords
keto
prostaglandin compound
composition
compound
prostaglandin
Prior art date
Application number
KR1019910011731A
Other languages
English (en)
Other versions
KR100195430B1 (ko
Inventor
류지 우에노
Original Assignee
우에노 류조
가부시끼가이샤 우에노세이야꾸오오요껭뀨죠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우에노 류조, 가부시끼가이샤 우에노세이야꾸오오요껭뀨죠 filed Critical 우에노 류조
Publication of KR920002151A publication Critical patent/KR920002151A/ko
Application granted granted Critical
Publication of KR100195430B1 publication Critical patent/KR100195430B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

내용 없음

Description

15 -케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

15-케토프로스타글라딘 화합물을 약학상 허용 가능한 담체, 희석제 또는 부형제와 함께 함유함을 특징으로 하는 염증성 질환 치료용 약학 조성물.
제1항에 있어서, 15-케토-프로스타글라딘 화합물이 16-모노-또는 디-할로-15-케토-프로스타글라딘 화합물인 조성물.
제1항에 있어서, 15-케토-프로스타글라딘 화합물이 13,14-디히드로-16-모노-또는 디-할로-15-케토-프로스타글란딘 화합물인 조성물.
제1항에 있어서, 15-케토-프로스타글란딘 화합물이 13,14-디히드로-16-모노-또는 디플루오로-15-케토-프로스타글라딘 화합물인 조성물.
제1항에 있어서, 15-케토-프로스타글라딘 화합물이 13,14-디히드로-6,15-디케트-프로스타글란딘 화합물인 조성물.
제1항에 있어서, 15-케토-프로스타글란딘 화합물이 15-케토-20-알킬-프로스타글란딘 화합물인 조성물.
제1항에 있어서, 15-케토-프로스타글란딘 화합물이 13,14-디히드로-15케토-알킬-프로스타글란딘 화합물인 조성물.
제1항에 있어서, 15-케토-프로스타글란딘 화합물이 13,14-디히드로-15-케토-20체틸-프로스타글란딘 화합물인 조성물.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910011731A 1990-07-10 1991-07-10 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료 KR100195430B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18496390 1990-07-10
JP184963/1990 1990-07-10

Publications (2)

Publication Number Publication Date
KR920002151A true KR920002151A (ko) 1992-02-28
KR100195430B1 KR100195430B1 (ko) 1999-06-15

Family

ID=16162415

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910011731A KR100195430B1 (ko) 1990-07-10 1991-07-10 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료

Country Status (10)

Country Link
US (1) US5346921A (ko)
EP (1) EP0467564B1 (ko)
JP (1) JP2562239B2 (ko)
KR (1) KR100195430B1 (ko)
AT (1) ATE137116T1 (ko)
CA (1) CA2046069C (ko)
DE (1) DE69118978T2 (ko)
DK (1) DK0467564T3 (ko)
ES (1) ES2089136T3 (ko)
GR (1) GR3019760T3 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230014960A (ko) * 2021-07-22 2023-01-31 정찬희 자석이 구비된 도어 잠금장치

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508302A (en) * 1994-09-28 1996-04-16 American Home Products Corporation Phospholipase A2 inhibitors
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
PT857718E (pt) * 1996-06-10 2002-11-29 Sucampo Ag Antagonista da endotelina
CA2279267C (en) 1997-11-28 2010-01-12 R-Tech Ueno, Ltd. Use of 15-ketoprostaglandin e compounds as endothelin antagonist
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
ES2221859T3 (es) 1999-10-15 2005-01-16 Sucampo Ag Composicion de compuestos biciclicos y procedimiento para su estabilizacion.
CA2445651C (en) * 2001-05-18 2011-08-09 Sucampo Ag Cathartic composition comprising halogenated prostaglandin derivatives
MXPA04001604A (es) * 2001-08-23 2004-07-08 Sucampo Ag Metodo y composicion para tratamiento de hipertension ocular y glaucoma.
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
EP2308495A1 (en) * 2005-03-04 2011-04-13 Sucampo AG Method and composition for treating peripheral vascular diseases
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
US20070037193A1 (en) * 2005-08-12 2007-02-15 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
CN103974705A (zh) * 2011-06-21 2014-08-06 株式会社·R-技术上野 用于炎症性疾病、过敏性疾病和自身免疫性疾病的药物组合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2321876A1 (fr) * 1975-08-29 1977-03-25 Roussel Uclaf Nouveaux derives cyclopentaniques, leur procede de preparation et leur application comme medicaments
US4097603A (en) * 1977-09-06 1978-06-27 The Upjohn Company Gastric cytoprotection with non-antisecretory doses of prostaglandins
NL8105635A (nl) * 1981-12-15 1983-07-01 Univ Erasmus Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
JPS59134746A (ja) * 1982-11-05 1984-08-02 ザ，プロクタ−，エンド，ギヤンブル，カンパニ− 新規プロスタグランジン類似体
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
US4612330A (en) * 1985-02-04 1986-09-16 Eli Lilly And Company Antiinflammatory method
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
EP0308135B1 (en) * 1987-09-18 1992-11-19 R-Tech Ueno Ltd. Ocular hypotensive agents
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
ES2055051T3 (es) * 1988-05-23 1994-08-16 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para la fabricacion de un medicamento eficaz para aumentar la presion sanguinea.
JP2515442B2 (ja) * 1990-05-01 1996-07-10 株式会社上野製薬応用研究所 膵臓疾患処置剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230014960A (ko) * 2021-07-22 2023-01-31 정찬희 자석이 구비된 도어 잠금장치

Also Published As

Publication number Publication date
EP0467564B1 (en) 1996-04-24
DE69118978D1 (de) 1996-05-30
DE69118978T2 (de) 1996-11-14
US5346921A (en) 1994-09-13
EP0467564A2 (en) 1992-01-22
JPH0532551A (ja) 1993-02-09
EP0467564A3 (en) 1992-07-08
ES2089136T3 (es) 1996-10-01
CA2046069A1 (en) 1992-01-11
ATE137116T1 (de) 1996-05-15
CA2046069C (en) 2002-04-09
KR100195430B1 (ko) 1999-06-15
DK0467564T3 (da) 1996-05-13
GR3019760T3 (en) 1996-07-31
JP2562239B2 (ja) 1996-12-11

Similar Documents

Publication Publication Date Title
KR920019342A (ko) 골질환 치료제
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
NO870241L (no) Hypoglykemiske tiazolidindioner.
DK0453127T3 (da) Behandling af katarakt med 15-keto-prostaglandinforbindelser
KR950700060A (ko) 운동 뉴우런 질병의 치료에 유용한 약품을 얻기 위한 2-아미노-6-트리플루오로메톡시 벤조티아졸(리루졸)의 사용(Application of 2-amino 6-trifluoromethoxy benzothiazole(riluzole) for obtaining a drug useful in the treatment of motor neuron diseases)
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
ATE79622T1 (de) 1,4-diazepine.
ES2145818T3 (es) Utilizacion de la (s)-(-)-alfa-etil-2-oxo-1-pirrolidin-acetamida para la preparacion de medicamentos destinados al tratamiento de la ansiedad.
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
DE60128100D1 (de) Analgetisches arzneimittel
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
KR910009271A (ko) 15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료
KR910018028A (ko) 15- 데히드록시-16-옥소프로스타글란딘 화합물에 의한 생화학적 치료
KR920003972A (ko) 프로스타시클린 화합물을 이용한 백내장 치료
MX9102181A (es) Iminobenzodiazepina para el tratamiento de desordenes del sueno

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110111

Year of fee payment: 13

EXPY Expiration of term